Marketing: Page 91
-
CHMP approves BMS' combo hep C therapy
The treatment is moving forward in Europe.
By Nicole Gray • June 30, 2014 -
Roche making $5 million milestone payment to Halozyme
The payment for the two companies' MabThera SC collaboration comes as the drug is launched in Europe.
By Nicole Gray • June 30, 2014 -
Explore the Trendline➔
Brian Tucker / BioPharma Dive/BioPharma Dive
TrendlineCommercialization
New drugs for obesity are becoming blockbusters, while Trump administration pressure is reshaping pharma marketing strategies ahead of looming patent cliffs.
By BioPharma Dive staff -
Eisai files NDA for lenvatinib in Japan
Thyroid cancer affects up to 29,000 people in Japan.
By Nicole Gray • June 27, 2014 -
FDA
FDA requests additional information on AstraZeneca's ovarian cancer drug
The agency has concerns related to efficacy and safety.
By Nicole Gray • June 26, 2014 -
High-dose liraglutide may be the next weight-loss breakthrough
It decreases risk of progression to diabetes in individuals with pre-diabetes.
By Nicole Gray • June 26, 2014 -
Valeant pursuing shareholder support in Allergan bid
Its takeover effort turns more aggressive.
By Nicole Gray • June 26, 2014 -
Inovio initiates early-stage clinical trials for cervical cancer drug
The candidate is part of the emerging class of immuno-oncologic drugs.
By Nicole Gray • June 25, 2014 -
Indian Health Ministry likely to expand list of essential medications, cap costs
The decision has major implications for American drug manufacturers.
By Nicole Gray • June 24, 2014 -
Kala Pharma advances clinical testing of ocular drug
The nanotechnology-based drug is being evaluated for use in dry eye disease and perisurgical inflammation of the eye.
By Nicole Gray • June 24, 2014 -
MacroGenic moves into phase 1 with new leukemia drug
This first-in-class candidate has a dual mechanism of action.
By Nicole Gray • June 24, 2014 -
Boehringer Ingelheim stops development of hepatitis C drug
The company cites the competitive landscape as the determining factor.
By Nicole Gray • June 24, 2014 -
NICE approves Effient for broader use
The product is now acceptable for treatment of many types of acute coronary syndrome.
By Nicole Gray • June 22, 2014 -
Sivextro approved for hard-to-treat skin infections
This is the second drug covered under the FDA's new Qualified Infectious Disease Program designation.
By Nicole Gray • June 22, 2014 -
Deep Dive
Theory can outrun reality on drug approval fast track
The designation can create a buzz that is often not justified.
By Nicole Gray • June 20, 2014 -
J&J rachets up R&D through 12 new alliances
The company has many collaborations underway.
By Nicole Gray • June 20, 2014 -
J&J acquires global rights to influenza drug
If approved, the vaccine would be a new treatment approach to an age-old viral condition.
By Nicole Gray • June 20, 2014 -
PhRMA highlights clinical development of drugs aimed at older Americans
For people over 65, 95% of healthcare spending is for chronic diseases.
By Nicole Gray • June 20, 2014 -
Bellerophon Therapeutics moves PAH treatment into phase II
This add-on therapy could help patients who need additional support despite receiving standard-of-care treatment.
By Nicole Gray • June 20, 2014 -
NICE: More novel anticoagulant use could reduce strokes
The British agency has recommended adding novel anticoagulants to formularies throughout the UK.
By Nicole Gray • June 18, 2014 -
Gardasil approved in EU for prevention of anal cancer
The drug now has an expanded therapeutic role in Europe that also includes HPV prevention in adolescents.
By Nicole Gray • June 18, 2014 -
Pfizer, Novartis push for approval of meningitis vaccines
The two companies each have developed a vaccine to prevent a virulent form of meningitis.
By Nicole Gray • June 18, 2014 -
New prescription erectile dysfunction cream introduced to UK
Vitaros (alprostadil cream) is the first cream available for treating erectile function.
By Nicole Gray • June 18, 2014 -
JNJ partners with Viiv to create new combo HIV drug
The medication could end up rivaling Atripla.
By Nicole Gray • June 17, 2014 -
Intarcia presents positive phase III data on a once-yearly diabetes drug
The new therapy may be the key to controlling high blood sugar levels. Intarcia presented positive data at ADA 2014.
By Nicole Gray • June 17, 2014 -
Sanofi, Medtronic team up to offer options for diabetes patients
The new partnership focuses on innovative drug-device breakthroughs.
By Nicole Gray • June 17, 2014
Previous
